Trastuzumab vs Trelagliptin Succinate

## Trastuzumab vs Trelagliptin Succinate: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Trelagliptin Succinate**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Trelagliptin Succinate — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Trelagliptin Succinate — Small molecule.